Prohibiting MG53 Phosphorylation Optimizes its Therapeutic Potential in Diabetes
Circ Res
.
2022 Dec 2;131(12):977-979.
doi: 10.1161/CIRCRESAHA.122.322132.
Epub 2022 Dec 1.
Authors
Duane D Hall
1
,
Qian Shi
1
,
Long-Sheng Song
1
Affiliation
1
Division of Cardiovascular Medicine, Department of Internal Medicine, Abboud Cardiovascular Research Center, Carver College of Medicine, University of Iowa.
PMID:
36454851
PMCID:
PMC9718506
DOI:
10.1161/CIRCRESAHA.122.322132
No abstract available
Publication types
Editorial
Comment
MeSH terms
Diabetes Mellitus* / therapy
Humans
Phosphorylation
Grants and funding
R01 HL130346/HL/NHLBI NIH HHS/United States
R01 HL157741/HL/NHLBI NIH HHS/United States
R01 HL157781/HL/NHLBI NIH HHS/United States